[Table/Fig-1]:

Clinical manifestations and haematologic index in patients with thalassemia intermedia

		Thalassemia Intermedia		p-value
		Pre treatment	Post treatment
Transfusion	yes	33(75%)	3(6.8%)	0.001
	No	11(25%)	41(93.2%)
Hospitalization	No	34(77.3%)	42(95.4%)	0.03
	1	2(4.5%)	1(2.3%)
	2	6(13.6%)	1(2.3%)
	3	2(4.5%)	0
Visit	no	2(4.5%)	38(86.4%)	0.04
	1-2	35(79.5%)	5(11.4%)
	3-4	7(15.9%)	1(2.3%)
Spleen	Nl	3(6.8%)	40(91%)	0.01
	3-6cm	41(93.2%)	4(9.1%)
Hb(g/l)	<6	4(9.1%)	2(4.5%)	0.04
	6-8	12(27.3%)	3(6.8%)
	8-10	23(52.3%)	5(11.4%)
	10-12	4(9.1%)	34(77.3%)
	>12	1(2.3%)	0
MCH	<20	7(15.9%)	2(4.5%)	0.03
	20-27	25(56.8%)	4(9.1%)
	27-30	8(18.2%)	13(29.5%)
	>30	4(9.1%)	25(56.8%)
HbF	<5%	1(2.3%)	1(2.3%)	0.03
	5-10%	1(2.3%)	1(2.3%)
	15-20%	2(4.5%)	1(2.3%)
	20-25%	11(25%)	8(18.2%)
	>25%	29(65.9%)	33(75%)
MCV	<80	30(68.2%)	5(11.4%)	0.01
	80-100	12(27.3%)	3(6.8%)
	>100	2(4.5%)	36(81.8%)